Summary of Resus Conference from March 29, 2018.
The Targeted temperature management Trial compared outcomes for therapeutic hypothermia at 33°C versus 36°C for cardiac arrest patients with persistent coma. It may very well be practice changing. Or maybe not. Before we can figure out what “truth” this research study may have uncovered, we will look at the development of therapeutic hypothermia and what the literature has already told us.
Interesting article published in JAMA about the use of beta-blockade in septic shock patients to improve cardiac dysfunction.